Atrion (ATRI) Stock Price, News & Analysis

Company Overview

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Key Stats

• Today's Range: N/A
• 50-Day Range: $456.25 to $459.92
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 23,283 shs
• Market Capitalization: $809.46 million
• P/E Ratio: 43.23
• Dividend Yield: 1.91%
• Price Target: N/A
• Consensus Rating: N/A

ATRI Stock Analysis - Frequently Asked Questions

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) released its earnings results on Friday, November, 1st. The medical instruments supplier reported $5.15 EPS for the quarter. The medical instruments supplier earned $38.88 million during the quarter. Atrion had a trailing twelve-month return on equity of 7.75% and a net margin of 10.60%.

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Atrion investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V).

Company Calendar

• Last Earnings: 11/01/2019
• Today: 4/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Health Care Supplies
• Current Symbol: NASDAQ:ATRI
• CIK: 701288
• Web: www.atrioncorp.com
• Phone: (972) 390-9800
• Fax: 972-396-7581
• Employees: 720
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $10.64
• Trailing P/E Ratio: 43.23
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $19.41 million
• Net Margins: 10.60%
• Pretax Margin: 12.22%
• Return on Equity: 7.75%
• Return on Assets: 7.12%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 9.18
• Quick Ratio: 3.06

Sales & Book Value

• Annual Sales: $181.60 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 23.37
• Book Value: $138.02 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,760,000
• Free Float: 1,358,000
• Market Cap: $809.46 million
• Optionable: Not Optionable
• Beta: 0.69